Evidence map›Paper›PMID 38900149›Full record

ArticleeLife2024

Spontaneous human CD8 T cell and autoimmune encephalomyelitis-induced CD4/CD8 T cell lesions in the brain and spinal cord of HLA-DRB1*15-positive multiple sclerosis humanized immune system mice.

Irini Papazian, Maria Kourouvani, Anastasia Dagkonaki, Vasileios Gouzouasis, Lila Dimitrakopoulou, Nikolaos Markoglou, Fotis Badounas, Theodore Tselios, Maria Anagnostouli, Lesley Probert

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Irini PapazianLaboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Maria KourouvaniLaboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Anastasia DagkonakiLaboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Vasileios GouzouasisLaboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Lila DimitrakopoulouDepartment of Hematology, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Nikolaos MarkoglouResearch Immunogenetics Laboratory, Multiple Sclerosis and Demyelinating Diseases Unit, First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, NKUA, Aeginition University Hospital, Athens, Greece.
Fotis BadounasLaboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.
Theodore TseliosDepartment of Chemistry, University of Patras, Patras, Greece.
Maria AnagnostouliResearch Immunogenetics Laboratory, Multiple Sclerosis and Demyelinating Diseases Unit, First Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, NKUA, Aeginition University Hospital, Athens, Greece.
Lesley ProbertLaboratory of Molecular Genetics, Hellenic Pasteur Institute, Athens, Greece.ORCID https://orcid.org/0000-0002-5931-2880

Funding

Hellenic Ministry of Development and Investment 2018ΣΕ01300001Hellenic Ministry of Development and Investment T1EDK-01859
6 · The paper itself

Abstract

Autoimmune diseases of the central nervous system (CNS) such as multiple sclerosis (MS) are only partially represented in current experimental models and the development of humanized immune mice is crucial for better understanding of immunopathogenesis and testing of therapeutics. We describe a humanized mouse model with several key features of MS. Severely immunodeficient B2m-NOG mice were transplanted with peripheral blood mononuclear cells (PBMCs) from HLA-DRB1-typed MS and healthy (HI) donors and showed rapid engraftment by human T and B lymphocytes. Mice receiving cells from MS patients with recent/ongoing Epstein-Barr virus reactivation showed high B cell engraftment capacity. Both HLA-DRB1*15 (DR15) MS and DR15 HI mice, not HLA-DRB1*13 MS mice, developed human T cell infiltration of CNS borders and parenchyma. DR15 MS mice uniquely developed inflammatory lesions in brain and spinal cord gray matter, with spontaneous, hCD8 T cell lesions, and mixed hCD8/hCD4 T cell lesions in EAE immunized mice, with variation in localization and severity between different patient donors. Main limitations of this model for further development are poor monocyte engraftment and lack of demyelination, lymph node organization, and IgG responses. These results show that PBMC humanized mice represent promising research tools for investigating MS immunopathology in a patient-specific approach.

Indexed as

BrainCD8-Positive T-LymphocytesDisease Models, AnimalHLA-DRB1 ChainsMultiple SclerosisSpinal CordAnimalsCD4-Positive T-LymphocytesEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansMiceHLA-DRB1*15 antigenHLA-DRB1 ChainsEpstein–Barr virus infection statusHLA-DRB1*15 MS risk factorhumanized miceimmunologyinflammationmousemultiple sclerosisnatalizumabneuroscienceperipheral blood mononuclear cells

Identifiers

PMID38900149
PMCPMC11189630

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.